国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Analysis of the Therapeutic Value of Kunxian Tablet in Medical Treatment and Its Adverse Consequences

John Sekh

Kunxian Tablet is a traditional Chinese herbal medicine with a long history of use in various therapeutic applications.
This abstract provides an overview of a comprehensive analysis of the therapeutic value and potential adverse
consequences associated with Kunxian Tablet in medical treatment. The study combines a review of existing literature,
clinical trials, and empirical evidence to assess the benefits and risks associated with its usage. The study emphasizes
the importance of proper dosage, patient selection, and healthcare provider supervision when considering the use
of Kunxian Tablet in medical treatment. To mitigate adverse consequences, it is crucial to promote evidence-based
medicine and adhere to good manufacturing practices in the production of herbal medicines. Kunxian Tablet presents a
promising avenue for therapeutic applications in traditional Chinese medicine. However, its use should be approached
with caution, considering potential adverse consequences and the need for further research and standardization in this
field. An informed and evidence-based approach is essential to harness the full therapeutic potential of Kunxian Tablet
while ensuring patient safety and well-being.